Mechanical Defects of Muscle Fibers with Myosin Light Chain Mutants That Cause Cardiomyopathy

Overview

Journal Biophys J

Publisher Cell Press

Specialty Biophysics

Date 2003 Apr 2

PMID 12668451

Citations 8

Authors

Osha Roopnarine

Affiliations

Soon will be listed here.

Abstract

Familial hypertrophic cardiomyopathy is a disease caused by single mutations in several sarcomeric proteins, including the human myosin ventricular regulatory light chain (vRLC). The effects of four of these mutations (A13T, F18L, E22K, and P95A) in vRLC on force generation were determined as a function of Ca(2+) concentration. The endogenous RLC was removed from skinned rabbit psoas muscle fibers, and replaced with either rat wildtype vRLC or recombinant rat vRLC (G13T, F18L, E22K, and P95A). Compared to fibers with wildtype rat vRLC, the E22K mutant increased Ca sensitivity of force generation, whereas the G13T and F18L mutants decreased the Ca sensitivity, and the P95A mutant had no significant effect. None of the RLC mutants affected the maximal tension (observed at saturating Ca(2+) concentrations), except for F18L, which decreased the maximal tension to 69 +/- 10% of the wildtype value. Of the mutant RLCs, only F18L decreased the cooperativity of activation of force generation. These results suggest that the primary cause of familial hypertrophic cardiomyopathy, in some cases, is perturbation in the Ca sensitivity of force generation, in which Ca-sensitizing or Ca-desensitizing effects can lead to similar disease phenotypes.

Citing Articles

Programmed Exercise Attenuates Familial Hypertrophic Cardiomyopathy in Transgenic E22K Mice Inhibition of PKC-α/NFAT Pathway.

Wang H, Lin Y, Zhang R, Chen Y, Ji W, Li S Front Cardiovasc Med. 2022; 9:808163.

PMID: 35265680 PMC: 8899095. DOI: 10.3389/fcvm.2022.808163.

From Genetic Mutations to Molecular Basis of Heart Failure Treatment: An Overview of the Mechanism and Implication of the Novel Modulators for Cardiac Myosin.

Chen Y, Chien C, Chiang C, Chen C, Cheng H Int J Mol Sci. 2021; 22(12).

PMID: 34205587 PMC: 8234187. DOI: 10.3390/ijms22126617.

Myosin lever arm orientation in muscle determined with high angular resolution using bifunctional spin labels.

Savich Y, Binder B, Thompson A, Thomas D J Gen Physiol. 2019; 151(8):1007-1016.

PMID: 31227551 PMC: 6683674. DOI: 10.1085/jgp.201812210.

Hereditary heart disease: pathophysiology, clinical presentation, and animal models of HCM, RCM, and DCM associated with mutations in cardiac myosin light chains.

Yadav S, Sitbon Y, Kazmierczak K, Szczesna-Cordary D Pflugers Arch. 2019; 471(5):683-699.

PMID: 30706179 PMC: 6476665. DOI: 10.1007/s00424-019-02257-4.

Molecular genetics and pathogenesis of cardiomyopathy.

Kimura A J Hum Genet. 2015; 61(1):41-50.

PMID: 26178429 DOI: 10.1038/jhg.2015.83.

References

Sanbe A, Nelson D, Gulick J, Setser E, Osinska H, Wang X . In vivo analysis of an essential myosin light chain mutation linked to familial hypertrophic cardiomyopathy. Circ Res. 2000; 87(4):296-302. DOI: 10.1161/01.res.87.4.296. View

Sanbe A, Fewell J, Gulick J, Osinska H, Lorenz J, Hall D . Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem. 1999; 274(30):21085-94. DOI: 10.1074/jbc.274.30.21085. View

Hernandez O, Housmans P, Potter J . Invited Review: pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation. J Appl Physiol (1985). 2001; 90(3):1125-36. DOI: 10.1152/jappl.2001.90.3.1125. View

Seidman J, Seidman C . The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001; 104(4):557-67. DOI: 10.1016/s0092-8674(01)00242-2. View

Martyn D, Gordon A . Influence of length on force and activation-dependent changes in troponin c structure in skinned cardiac and fast skeletal muscle. Biophys J. 2001; 80(6):2798-808. PMC: 1301465. DOI: 10.1016/S0006-3495(01)76247-9. View

Szczesna D, Ghosh D, Li Q, Gomes A, Guzman G, Arana C . Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J Biol Chem. 2000; 276(10):7086-92. DOI: 10.1074/jbc.M009823200. View

Gordon A, Regnier M, Homsher E . Skeletal and cardiac muscle contractile activation: tropomyosin "rocks and rolls". News Physiol Sci. 2001; 16:49-55. View

Andersen P, Havndrup O, Bundgaard H, Moolman-Smook J, Larsen L, Mogensen J . Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. J Med Genet. 2001; 38(12):E43. PMC: 1734772. DOI: 10.1136/jmg.38.12.e43. View

Thomas D, Prochniewicz E, Roopnarine O . Changes in actin and myosin structural dynamics due to their weak and strong interactions. Results Probl Cell Differ. 2002; 36:7-19. PMC: 10712373. DOI: 10.1007/978-3-540-46558-4_2. View

10.

Roopnarine O . Familial hypertrophic cardiomyopathic myosin mutations that affect the actin-myosin interaction. Results Probl Cell Differ. 2002; 36:75-86. DOI: 10.1007/978-3-540-46558-4_7. View

11.

Potter J . Preparation of troponin and its subunits. Methods Enzymol. 1982; 85 Pt B:241-63. DOI: 10.1016/0076-6879(82)85024-6. View

12.

Wagner P . Preparation and fractionation of myosin light chains and exchange of the essential light chains. Methods Enzymol. 1982; 85 Pt B:72-81. DOI: 10.1016/0076-6879(82)85010-6. View

13.

Persechini A, Stull J, Cooke R . The effect of myosin phosphorylation on the contractile properties of skinned rabbit skeletal muscle fibers. J Biol Chem. 1985; 260(13):7951-4. View

14.

Moss R, Giulian G, Greaser M . The effects of partial extraction of TnC upon the tension-pCa relationship in rabbit skinned skeletal muscle fibers. J Gen Physiol. 1985; 86(4):585-600. PMC: 2228809. DOI: 10.1085/jgp.86.4.585. View

15.

Metzger J, Greaser M, Moss R . Variations in cross-bridge attachment rate and tension with phosphorylation of myosin in mammalian skinned skeletal muscle fibers. Implications for twitch potentiation in intact muscle. J Gen Physiol. 1989; 93(5):855-83. PMC: 2216237. DOI: 10.1085/jgp.93.5.855. View

16.

HUBER P, Brunner U, Schaub M . Disulfide formation within the regulatory light chain of skeletal muscle myosin. Biochemistry. 1989; 28(23):9116-23. DOI: 10.1021/bi00449a024. View

17.

Hofmann P, Metzger J, Greaser M, Moss R . Effects of partial extraction of light chain 2 on the Ca2+ sensitivities of isometric tension, stiffness, and velocity of shortening in skinned skeletal muscle fibers. J Gen Physiol. 1990; 95(3):477-98. PMC: 2216322. DOI: 10.1085/jgp.95.3.477. View

18.

Fitzsimons D, Bodell P, Baldwin K . Myocardial functional correlates of cardiac myosin light chain 2 phosphorylation. J Appl Physiol (1985). 1990; 68(6):2426-33. DOI: 10.1152/jappl.1990.68.6.2426. View

19.

Kerrick W, Potter J, Hoar P . The apparent rate constant for the dissociation of force generating myosin crossbridges from actin decreases during Ca2+ activation of skinned muscle fibres. J Muscle Res Cell Motil. 1991; 12(1):53-60. DOI: 10.1007/BF01781174. View

20.

Morano I . Effects of different expression and posttranslational modifications of myosin light chains on contractility of skinned human cardiac fibers. Basic Res Cardiol. 1992; 87 Suppl 1:129-41. DOI: 10.1007/978-3-642-72474-9_11. View